EX9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Exelixis Inc

Watchlist Manager

Watchlist

Price: 43.49 EUR -1.08% Market Closed

Market Cap: €12.7B

E	Exelixis Inc XMUN:EX9	US
	Centessa Pharmaceuticals PLC F:260	UK
	WuXi Biologics (Cayman) Inc F:1FW2	CN
	Duerr AG F:DUE	DE
F	Fortec Elektronik AG DUS:FEV	DE
V	Vinci SA XMUN:SQU	FR
M	Madrigal Pharmaceuticals Inc F:YDO1	US
F	Fielmann Group AG DUS:FIE	DE
V	Very Good Food Company Inc DUS:0SI	CA
B	Basf Se XMUN:BAS	DE
T	Teixeira Duarte SA F:TXC2	PT
H	High Tide Inc XMUN:2LYA	CA
C	China Minsheng Banking Corp Ltd F:GHFH	CN
D	Danone SA SIX:DAN	FR

Profitability Summary

Exelixis Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

96%

Strong 3Y Average Gross Margin

96%

Declining Gross Margin

96% > 96%

Exceptional Operating Margin

39%

Sustainable 3Y Average Operating Margin

25%

Operating Margin is Increasing

9% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

9% > 35%

Exceptional Free Cash Flow Margin

39%

Strong 3Y Average Free Cash Flow Margin

27%

Free Cash Flow Margin is Increasing

16% > 39%

Exceptional ROE

40%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

ROIC is Increasing

8% > 43%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.